Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices lift
Go back to Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices lift| Abbott Laboratories (NYSE: ABT) | Delayed: 103.04 +0.43 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.61 | 52 Week High | $46.38 | |||
| Open | $102.27 | 52 Week Low | $36.00 | |||
| Day High | $103.20 | P/E | 68.69 | |||
| Day Low | $101.84 | EPS | $1.50 | |||
| Volume | 2,815,793 | |||||
